The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications

At laparotomy, many surgeons routinely instill crystalloid solutions into the peritoneal cavity, presumably to dilute out necrotic debris, bacteria, and adjuvant substances which foster bacterial growth. We examined the effect on mortality, bacterial growth, clearance, and phagocytosis of various vo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgery 1984, Vol.199 (1), p.37-43
Hauptverfasser: DUNN, D. L, BARKE, R. A, AHRENHOLZ, D. H, HUMPHREY, E. W, SIMMONS, R. L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 43
container_issue 1
container_start_page 37
container_title Annals of surgery
container_volume 199
creator DUNN, D. L
BARKE, R. A
AHRENHOLZ, D. H
HUMPHREY, E. W
SIMMONS, R. L
description At laparotomy, many surgeons routinely instill crystalloid solutions into the peritoneal cavity, presumably to dilute out necrotic debris, bacteria, and adjuvant substances which foster bacterial growth. We examined the effect on mortality, bacterial growth, clearance, and phagocytosis of various volumes of saline instilled into the peritoneal cavity of rats during Escherichia coli peritonitis. Minimal intraperitoneal bacterial growth was seen after the introduction of a nonlethal inoculum of viable E. coli in 1 ml of saline, while administration of an identical inoculum in 30 ml of saline intraperitoneally (i.p.) led to increased 48-hour mortality (p less than 0.01), and associated rapid bacterial proliferation (p less than 0.01). Clearance of nonviable radiolabelled E. coli from the peritoneal cavity was delayed, bacterial association with host peritoneal leukocytes was decreased, and blood uptake of radiolabelled bacteria was diminished in animals receiving 30 ml of saline i.p., compared to controls which received the identical inoculum in 1 ml of saline i.p. The clinical relevance of these studies is manifold: (1) they provide a possible explanation why patients with ascites due to cirrhosis or the nephrotic syndrome, or those patients undergoing peritoneal dialysis are more susceptible to primary and secondary bacterial peritonitis, possibly on the basis of impaired peritoneal clearance or diminished phagocytosis and, (2) although irrigation of the peritoneal cavity with crystalloid solution would seem prudent during laparotomy, these solutions must be removed prior to closure to prevent interference with normal peritoneal host defense mechanisms.
doi_str_mv 10.1097/00000658-198401000-00007
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1353255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80927479</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-a9199c0dcfbed80564af19f1ba95de09096483d45a8878273d7cb0c11e3431073</originalsourceid><addsrcrecordid>eNpVUU1v3CAURFWjdJv0J1TiUPXmlGfAwKVSFfVLSpVLckYsPLpENt4aO2r_fXHjrlouwMy8YcQQQoFdATPqHVtXJ3UDRgsG9dKsiHpGdiDbCoNgz8muQrwRhrcvyMtSHhgDoZk6J-cd71qp2x053B2QuvCwPLo8U4wR_UzHSI84pXnM6Hoa-yUFmjLFnys6YJ4rugnSnMoV_Yb-4HIqA3U5UN-nnHzVpOHY18OcxlwuyVl0fcFX235B7j99vLv-0tzcfv56_eGm8ZybuXEGjPEs-LjHoJnshItgIuydkQGZYaYTmgchndZKt4oH5ffMAyAXHJjiF-T9k-9x2Q8YfE07ud4ea3A3_bKjS_Z_JqeD_T4-WuCSt1JWg7ebwTT-WLDMdkjFY9-7jONSrGamVUKZKtRPQj-NpUwYT48As2tL9m9L9tTSH2gN-frfkKfBrZbKv9l4V-pHxslln8pJZqSQwIH_Bhp8nG0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80927479</pqid></control><display><type>article</type><title>The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>DUNN, D. L ; BARKE, R. A ; AHRENHOLZ, D. H ; HUMPHREY, E. W ; SIMMONS, R. L</creator><creatorcontrib>DUNN, D. L ; BARKE, R. A ; AHRENHOLZ, D. H ; HUMPHREY, E. W ; SIMMONS, R. L</creatorcontrib><description>At laparotomy, many surgeons routinely instill crystalloid solutions into the peritoneal cavity, presumably to dilute out necrotic debris, bacteria, and adjuvant substances which foster bacterial growth. We examined the effect on mortality, bacterial growth, clearance, and phagocytosis of various volumes of saline instilled into the peritoneal cavity of rats during Escherichia coli peritonitis. Minimal intraperitoneal bacterial growth was seen after the introduction of a nonlethal inoculum of viable E. coli in 1 ml of saline, while administration of an identical inoculum in 30 ml of saline intraperitoneally (i.p.) led to increased 48-hour mortality (p less than 0.01), and associated rapid bacterial proliferation (p less than 0.01). Clearance of nonviable radiolabelled E. coli from the peritoneal cavity was delayed, bacterial association with host peritoneal leukocytes was decreased, and blood uptake of radiolabelled bacteria was diminished in animals receiving 30 ml of saline i.p., compared to controls which received the identical inoculum in 1 ml of saline i.p. The clinical relevance of these studies is manifold: (1) they provide a possible explanation why patients with ascites due to cirrhosis or the nephrotic syndrome, or those patients undergoing peritoneal dialysis are more susceptible to primary and secondary bacterial peritonitis, possibly on the basis of impaired peritoneal clearance or diminished phagocytosis and, (2) although irrigation of the peritoneal cavity with crystalloid solution would seem prudent during laparotomy, these solutions must be removed prior to closure to prevent interference with normal peritoneal host defense mechanisms.</description><identifier>ISSN: 0003-4932</identifier><identifier>EISSN: 1528-1140</identifier><identifier>DOI: 10.1097/00000658-198401000-00007</identifier><identifier>PMID: 6362582</identifier><identifier>CODEN: ANSUA5</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Adjuvants, Immunologic - immunology ; Animals ; Ascitic Fluid - immunology ; Ascitic Fluid - microbiology ; Bacterial diseases ; Bacterial diseases of the digestive system and abdomen ; Biological and medical sciences ; Blood - microbiology ; Escherichia coli - growth &amp; development ; Escherichia coli Infections - immunology ; Human bacterial diseases ; Infectious diseases ; Male ; Medical sciences ; Peritoneal Cavity - immunology ; Peritoneal Cavity - microbiology ; Peritonitis - microbiology ; Peritonitis - prevention &amp; control ; Phagocytosis ; Rats ; Sodium Chloride - administration &amp; dosage ; Therapeutic Irrigation</subject><ispartof>Annals of surgery, 1984, Vol.199 (1), p.37-43</ispartof><rights>1984 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1353255/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1353255/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,4021,27921,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9545131$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6362582$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DUNN, D. L</creatorcontrib><creatorcontrib>BARKE, R. A</creatorcontrib><creatorcontrib>AHRENHOLZ, D. H</creatorcontrib><creatorcontrib>HUMPHREY, E. W</creatorcontrib><creatorcontrib>SIMMONS, R. L</creatorcontrib><title>The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications</title><title>Annals of surgery</title><addtitle>Ann Surg</addtitle><description>At laparotomy, many surgeons routinely instill crystalloid solutions into the peritoneal cavity, presumably to dilute out necrotic debris, bacteria, and adjuvant substances which foster bacterial growth. We examined the effect on mortality, bacterial growth, clearance, and phagocytosis of various volumes of saline instilled into the peritoneal cavity of rats during Escherichia coli peritonitis. Minimal intraperitoneal bacterial growth was seen after the introduction of a nonlethal inoculum of viable E. coli in 1 ml of saline, while administration of an identical inoculum in 30 ml of saline intraperitoneally (i.p.) led to increased 48-hour mortality (p less than 0.01), and associated rapid bacterial proliferation (p less than 0.01). Clearance of nonviable radiolabelled E. coli from the peritoneal cavity was delayed, bacterial association with host peritoneal leukocytes was decreased, and blood uptake of radiolabelled bacteria was diminished in animals receiving 30 ml of saline i.p., compared to controls which received the identical inoculum in 1 ml of saline i.p. The clinical relevance of these studies is manifold: (1) they provide a possible explanation why patients with ascites due to cirrhosis or the nephrotic syndrome, or those patients undergoing peritoneal dialysis are more susceptible to primary and secondary bacterial peritonitis, possibly on the basis of impaired peritoneal clearance or diminished phagocytosis and, (2) although irrigation of the peritoneal cavity with crystalloid solution would seem prudent during laparotomy, these solutions must be removed prior to closure to prevent interference with normal peritoneal host defense mechanisms.</description><subject>Adjuvants, Immunologic - immunology</subject><subject>Animals</subject><subject>Ascitic Fluid - immunology</subject><subject>Ascitic Fluid - microbiology</subject><subject>Bacterial diseases</subject><subject>Bacterial diseases of the digestive system and abdomen</subject><subject>Biological and medical sciences</subject><subject>Blood - microbiology</subject><subject>Escherichia coli - growth &amp; development</subject><subject>Escherichia coli Infections - immunology</subject><subject>Human bacterial diseases</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Peritoneal Cavity - immunology</subject><subject>Peritoneal Cavity - microbiology</subject><subject>Peritonitis - microbiology</subject><subject>Peritonitis - prevention &amp; control</subject><subject>Phagocytosis</subject><subject>Rats</subject><subject>Sodium Chloride - administration &amp; dosage</subject><subject>Therapeutic Irrigation</subject><issn>0003-4932</issn><issn>1528-1140</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1v3CAURFWjdJv0J1TiUPXmlGfAwKVSFfVLSpVLckYsPLpENt4aO2r_fXHjrlouwMy8YcQQQoFdATPqHVtXJ3UDRgsG9dKsiHpGdiDbCoNgz8muQrwRhrcvyMtSHhgDoZk6J-cd71qp2x053B2QuvCwPLo8U4wR_UzHSI84pXnM6Hoa-yUFmjLFnys6YJ4rugnSnMoV_Yb-4HIqA3U5UN-nnHzVpOHY18OcxlwuyVl0fcFX235B7j99vLv-0tzcfv56_eGm8ZybuXEGjPEs-LjHoJnshItgIuydkQGZYaYTmgchndZKt4oH5ffMAyAXHJjiF-T9k-9x2Q8YfE07ud4ea3A3_bKjS_Z_JqeD_T4-WuCSt1JWg7ebwTT-WLDMdkjFY9-7jONSrGamVUKZKtRPQj-NpUwYT48As2tL9m9L9tTSH2gN-frfkKfBrZbKv9l4V-pHxslln8pJZqSQwIH_Bhp8nG0</recordid><startdate>1984</startdate><enddate>1984</enddate><creator>DUNN, D. L</creator><creator>BARKE, R. A</creator><creator>AHRENHOLZ, D. H</creator><creator>HUMPHREY, E. W</creator><creator>SIMMONS, R. L</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>1984</creationdate><title>The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications</title><author>DUNN, D. L ; BARKE, R. A ; AHRENHOLZ, D. H ; HUMPHREY, E. W ; SIMMONS, R. L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-a9199c0dcfbed80564af19f1ba95de09096483d45a8878273d7cb0c11e3431073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Adjuvants, Immunologic - immunology</topic><topic>Animals</topic><topic>Ascitic Fluid - immunology</topic><topic>Ascitic Fluid - microbiology</topic><topic>Bacterial diseases</topic><topic>Bacterial diseases of the digestive system and abdomen</topic><topic>Biological and medical sciences</topic><topic>Blood - microbiology</topic><topic>Escherichia coli - growth &amp; development</topic><topic>Escherichia coli Infections - immunology</topic><topic>Human bacterial diseases</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Peritoneal Cavity - immunology</topic><topic>Peritoneal Cavity - microbiology</topic><topic>Peritonitis - microbiology</topic><topic>Peritonitis - prevention &amp; control</topic><topic>Phagocytosis</topic><topic>Rats</topic><topic>Sodium Chloride - administration &amp; dosage</topic><topic>Therapeutic Irrigation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DUNN, D. L</creatorcontrib><creatorcontrib>BARKE, R. A</creatorcontrib><creatorcontrib>AHRENHOLZ, D. H</creatorcontrib><creatorcontrib>HUMPHREY, E. W</creatorcontrib><creatorcontrib>SIMMONS, R. L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DUNN, D. L</au><au>BARKE, R. A</au><au>AHRENHOLZ, D. H</au><au>HUMPHREY, E. W</au><au>SIMMONS, R. L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications</atitle><jtitle>Annals of surgery</jtitle><addtitle>Ann Surg</addtitle><date>1984</date><risdate>1984</risdate><volume>199</volume><issue>1</issue><spage>37</spage><epage>43</epage><pages>37-43</pages><issn>0003-4932</issn><eissn>1528-1140</eissn><coden>ANSUA5</coden><abstract>At laparotomy, many surgeons routinely instill crystalloid solutions into the peritoneal cavity, presumably to dilute out necrotic debris, bacteria, and adjuvant substances which foster bacterial growth. We examined the effect on mortality, bacterial growth, clearance, and phagocytosis of various volumes of saline instilled into the peritoneal cavity of rats during Escherichia coli peritonitis. Minimal intraperitoneal bacterial growth was seen after the introduction of a nonlethal inoculum of viable E. coli in 1 ml of saline, while administration of an identical inoculum in 30 ml of saline intraperitoneally (i.p.) led to increased 48-hour mortality (p less than 0.01), and associated rapid bacterial proliferation (p less than 0.01). Clearance of nonviable radiolabelled E. coli from the peritoneal cavity was delayed, bacterial association with host peritoneal leukocytes was decreased, and blood uptake of radiolabelled bacteria was diminished in animals receiving 30 ml of saline i.p., compared to controls which received the identical inoculum in 1 ml of saline i.p. The clinical relevance of these studies is manifold: (1) they provide a possible explanation why patients with ascites due to cirrhosis or the nephrotic syndrome, or those patients undergoing peritoneal dialysis are more susceptible to primary and secondary bacterial peritonitis, possibly on the basis of impaired peritoneal clearance or diminished phagocytosis and, (2) although irrigation of the peritoneal cavity with crystalloid solution would seem prudent during laparotomy, these solutions must be removed prior to closure to prevent interference with normal peritoneal host defense mechanisms.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>6362582</pmid><doi>10.1097/00000658-198401000-00007</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-4932
ispartof Annals of surgery, 1984, Vol.199 (1), p.37-43
issn 0003-4932
1528-1140
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1353255
source MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adjuvants, Immunologic - immunology
Animals
Ascitic Fluid - immunology
Ascitic Fluid - microbiology
Bacterial diseases
Bacterial diseases of the digestive system and abdomen
Biological and medical sciences
Blood - microbiology
Escherichia coli - growth & development
Escherichia coli Infections - immunology
Human bacterial diseases
Infectious diseases
Male
Medical sciences
Peritoneal Cavity - immunology
Peritoneal Cavity - microbiology
Peritonitis - microbiology
Peritonitis - prevention & control
Phagocytosis
Rats
Sodium Chloride - administration & dosage
Therapeutic Irrigation
title The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A02%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20adjuvant%20effect%20of%20peritoneal%20fluid%20in%20experimental%20peritonitis.%20Mechanism%20and%20clinical%20implications&rft.jtitle=Annals%20of%20surgery&rft.au=DUNN,%20D.%20L&rft.date=1984&rft.volume=199&rft.issue=1&rft.spage=37&rft.epage=43&rft.pages=37-43&rft.issn=0003-4932&rft.eissn=1528-1140&rft.coden=ANSUA5&rft_id=info:doi/10.1097/00000658-198401000-00007&rft_dat=%3Cproquest_pubme%3E80927479%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80927479&rft_id=info:pmid/6362582&rfr_iscdi=true